{"id":"https://openalex.org/W82350142","doi":null,"title":"Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective.","display_name":"Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective.","publication_year":2001,"publication_date":"2001-11-01","ids":{"openalex":"https://openalex.org/W82350142","mag":"82350142","pmid":"https://pubmed.ncbi.nlm.nih.gov/11695253"},"language":"en","primary_location":{"id":"pmid:11695253","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11695253","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental rheumatology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027292872","display_name":"Kay Brune","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K Brune","raw_affiliation_strings":["Institute for Pharmacology and Toxicology, University of Erlangen, Fahrstrasse 17, 91054 Erlangen, Germany. Kay.Brune@pharmakologie.uni-erlangen.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Pharmacology and Toxicology, University of Erlangen, Fahrstrasse 17, 91054 Erlangen, Germany. Kay.Brune@pharmakologie.uni-erlangen.de","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029303678","display_name":"Antje C. Neubert","orcid":"https://orcid.org/0000-0001-6575-1452","observed_orcids":["https://orcid.org/0000-0001-6575-1452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Neubert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1659,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.77478494,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"19","issue":"6 Suppl 25","first_page":"S51","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.847000002861023},{"id":"https://openalex.org/keywords/cox-1","display_name":"cyclooxygenase-1","score":0.8569999933242798},{"id":"https://openalex.org/keywords/aspirin-like-drugs","display_name":"aspirin-like drugs","score":0.6949999928474426},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.8690000176429749},{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":1.0},{"id":"https://openalex.org/keywords/ibuprofen","display_name":"ibuprofen","score":0.8690000176429749},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7870000004768372},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8019999861717224},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.6850000023841858},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.7540000081062317},{"id":"https://openalex.org/keywords/anti-inflammatory-efficacy","display_name":"anti-inflammatory efficacy","score":0.7059999704360962},{"id":"https://openalex.org/keywords/analgesics","display_name":"analgesics","score":0.6919999718666077},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.7129999995231628},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.9429171085357666},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.8212262392044067},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.794609010219574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7475981116294861},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.7458764314651489},{"id":"https://openalex.org/C2779826273","wikidata":"https://www.wikidata.org/wiki/Q244408","display_name":"Diclofenac","level":2,"score":0.729641318321228},{"id":"https://openalex.org/C2778722691","wikidata":"https://www.wikidata.org/wiki/Q57055","display_name":"Acetaminophen","level":2,"score":0.6926318407058716},{"id":"https://openalex.org/C2778115740","wikidata":"https://www.wikidata.org/wiki/Q1215575","display_name":"Naproxen","level":3,"score":0.6560488939285278},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6356183290481567},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.6343278884887695},{"id":"https://openalex.org/C2779252780","wikidata":"https://www.wikidata.org/wiki/Q582687","display_name":"Antipyretic","level":3,"score":0.6279333829879761},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.5171651244163513},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.49580392241477966},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.45121410489082336},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.4459395110607147},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.41273078322410583},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.25715890526771545},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19925686717033386},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15386363863945007},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1467055082321167},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0741054117679596},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007052","descriptor_name":"Ibuprofen","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010600","descriptor_name":"Pharmacology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018712","descriptor_name":"Analgesics, Non-Narcotic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11695253","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11695253","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental rheumatology","raw_type":"Journal Article"},{"id":"mag:82350142","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11695253","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2061630657","https://openalex.org/W2063369648","https://openalex.org/W6983678087","https://openalex.org/W2158735781","https://openalex.org/W1966347882","https://openalex.org/W2018185729","https://openalex.org/W1969460471","https://openalex.org/W2115189126","https://openalex.org/W2412403023","https://openalex.org/W2138224872"],"abstract_inverted_index":{"Two":[0],"classes":[1,48],"of":[2,30,41,113,184,194,213,221,230,241,270],"antipyretic":[3],"analgesics":[4],"were":[5],"developed":[6],"about":[7],"100":[8],"years":[9],"ago,":[10],"namely":[11],"the":[12,27,31,38,42,50,86,95,111,114,135,151,173,181,185,192,195,207,211,228,242,259,267],"acidic":[13,32,78,102,188],"aspirin-like":[14,34,58],"drugs":[15,35,59,79,147,190],"and":[16,36,53,91,108,118,125,172,205,233],"non-acidic":[17,43,122,146],"acetaminophen-phenazone-like":[18,44],"compounds.":[19,45],"Since":[20],"then,":[21],"research":[22],"has":[23,158],"aimed":[24],"at":[25,206],"improving":[26,37],"side-effect":[28],"profile":[29],"anti-inflammatory":[33,39,75,203,278],"efficacy":[40],"Both":[46],"drug":[47,257],"inhibit":[49],"cyclooxygenase":[51],"(COX)-1":[52],"-2":[54],"enzymes":[55],"non-selectively.":[56],"The":[57],"achieve":[60,201],"particularly":[61],"high":[62,83],"concentrations":[63,84],"in":[64,85,94,165,198],"inflamed":[65],"tissue,":[66],"which":[67],"is":[68,272],"assumed":[69],"to":[70,130,134,161,179,200,247,274],"account":[71],"for":[72,140,154,226,263],"their":[73],"superior":[74,277],"potency.":[76],"These":[77,145],"also":[80],"reach":[81],"comparatively":[82],"stomach":[87],"wall,":[88],"kidney":[89],"cortex":[90],"blood,":[92],"resulting":[93],"well-known":[96],"side":[97,214,223],"effects":[98,224],"that":[99,255],"occur":[100],"with":[101,106,191,266],"compounds":[103],"but":[104],"not":[105],"acetaminophen":[107],"phenazone.":[109],"Following":[110],"discovery":[112],"two":[115,121],"differentially":[116],"distributed":[117],"regulated":[119],"COXs,":[120],"COX-2-selective":[123],"compounds--celecoxib":[124],"rofecoxib--were":[126],"introduced.":[127],"They":[128],"proved":[129],"be":[131,162,219,275],"less":[132],"toxic":[133],"gastrointestinal":[136],"tract":[137],"compared":[138],"with,":[139],"example,":[141,227,264],"diclofenac":[142],"or":[143],"naproxen.":[144],"distribute":[148],"homogeneously":[149],"throughout":[150],"body--a":[152],"cause":[153],"concern":[155],"since":[156],"COX-2":[157,196,238,268],"been":[159],"found":[160],"present":[163],"constitutively":[164],"many":[166],"organ":[167],"systems,":[168],"including":[169],"brain,":[170],"bone":[171],"genito-urinary":[174],"tract.":[175],"It":[176],"appears":[177],"desirable":[178],"combine":[180],"tissue-targeted":[182],"distribution":[183],"highly":[186],"protein-bound":[187],"aspirin-type":[189],"selectivity":[193,269],"inhibitors,":[197],"order":[199],"improved":[202],"activity":[204],"same":[208],"time":[209],"reduce":[210],"risk":[212],"effects.":[215],"Such":[216],"agents":[217],"should":[218,234],"devoid":[220],"COX-1-related":[222],"in,":[225],"inhibition":[229],"blood":[231],"coagulation":[232],"only":[235],"weakly":[236],"affect":[237],"related":[239],"functions":[240],"central":[243],"nervous":[244],"system,":[245],"due":[246],"slow":[248],"blood-brain":[249],"barrier":[250],"penetration.":[251],"We":[252],"therefore":[253],"propose":[254],"a":[256,276],"combining":[258],"pharmacokinetic":[260],"characteristics":[261],"of,":[262],"ibuprofen":[265],"rofecoxib":[271],"likely":[273],"analgesic.":[279]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}